Integrity Orthopaedics, a company providing solutions for soft tissue repair, secures $20.6Million in Series B Round Funding.
Piper Sandler Merchant Banking and an unnamed current investor led the investment. With the money, the business plans to increase the scope of its first product’s US commercial debut in the rotator cuff repair market.
Integrity Orthopaedics, co-founded in 2020 by Thomas Westling, David Crompton, Drs. Patrick Connor, Howard Harris, and Marc Labbe, is dedicated to redefining soft tissue repair, beginning with rotator cuff repair. By enabling initial repair strength and fostering an ideal healing environment, the company hopes to overcome the limitations of traditional techniques.
Its system uses patented micro-anchors, a continuous, locking stitch, a patented instrument for anchor installation, and operative techniques to help doctors improve the fixation and healing of torn tendons. It was FDA cleared in early 2023 and initially used by a small number of surgeons in a limited launch.
Read also – CA-based Enlaza Therapeutics Secures $100Million in Series A Round Funding – FUNDING NEWS
The firm has started to gradually grow its field sales staff in order to collaborate with creative orthopedists in a few national marketplaces. As Integrity Orthopaedics increases workforce, production quantities, and physician education resources, it is anticipated that this rollout will gradually expand.
About Integrity Orthopaedics
Integrity Orthopaedics is a cutting-edge organisation committed to changing the field of soft tissue restoration. Their goal is to completely transform the way rotator cuff repair is done by permitting strong initial repair strength and creating an ideal healing environment, thereby surpassing the constraints of previous methods.
